Axsome Therapeutics Price Target Cut to $247.00/Share From $251.00 by Morgan Stanley
Ratings actions from Benzinga: GMT) Axsome Therapeutics Is Maintained at Equal-Weight by Morgan StanleyRatings actions from Benzinga
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.